Sponsor:
Université de Sherbrooke
Code:
NCT04766580
Conditions
Attention Deficit Disorder With Hyperactivity
Placebo Effect
Nocebo Effect
Pain
Eligibility Criteria
Sex: All
Age: 8 - 9
Healthy Volunteers: Accepted
Interventions
Placebo and nocebo effect
Brief summary:
Conditions
Attention Deficit Disorder With Hyperactivity
Placebo Effect
Nocebo Effect
Pain
Study ID
NCT04766580
Start date
Feb 17, 2021
Status verified date
Jul, 2022
Completion date
Jun 30, 2023
Anticipated
Primary completion date
Dec 30, 2022
Anticipated
Eligibility Criteria
Sex: All
Age: 8 - 9
Healthy Volunteers: Accepted
Enrollment
44 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
experimental: Children with ADHD group
active comparator: Children with no ADHD group
Interventions
Placebo and nocebo effect
Primary outcome measure
Central contacts
Carmen-Édith Belleï-Rodriguez, ps.ed., MSc
+1 819-780-2220carmen-edith.bellei-rodriguez@usherbrooke.caLocations
Centre de recherche sur le vieillissement (CdRV)
Recruiting
Sherbrooke, Quebec, Canada, J1H 4C4
Contacts
Sponsor
Université de Sherbrooke
Last update posted
Jul 28, 2022
Last verified
Jul, 2022
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Université de Sherbrooke on 2022-07-28.